View Post

Triple-negative breast cancer: Is a new treatment within reach?

In In The News by Barbara Jacoby0 Comments

By: Maria Cohut From: medicalnewstoday.com Researchers are currently investigating a potential new avenue for the treatment of triple-negative breast cancer, which is a particularly aggressive breast cancer subtype.  Triple-negative breast cancer is a type of breast cancer wherein the tumors do not express estrogen receptor, progesterone receptor, or the genes that promote the production of a protein called HER2, which …

View Post

Surgeons play big role in women’s choices for breast cancer care

In In The News by Barbara Jacoby0 Comments

From: HealthDay Published: chicagotribune.com A breast cancer patient’s choice of surgeon can have a major effect on her treatment, according to a new study. That’s because surgeons have a strong influence on whether early stage cancer patients have both breasts removed even when cancer is found in only one breast — a procedure called contralateral prophylactic mastectomy (CPM). Researchers surveyed …

View Post

New Publication Confirms Patient Ease of Use for AirXpanders’ AeroForm Tissue Expander System

In In The News by Barbara Jacoby0 Comments

AirXpanders, Inc. (ASX: AXP) (AirXpanders or Company), a medical device company focused on the design, manufacture, sale and distribution of the AeroForm® Tissue Expander System, today announced that a new publication in the July/September issue of Plastic Surgical Nursing (PSN) reinforced that patients undergoing breast reconstruction found the AeroForm dosage controller easy to use for breast tissue expansion. AeroForm offers …

View Post

Underreported Complication From Breast Cancer Treatment Gets New Attention And Hope For Improved Care

In In The News by Barbara Jacoby0 Comments

Source: Montefiore Health System From: PR Newswire International Panel Delivers Lymphedema Diagnosis and Treatment Standards for the First Time Breast cancer related lymphedema (BCRL), a common and painful, yet underreported side effect of surgery and radiation, is getting fresh attention, courtesy of new guidelines from internationally recognized breast surgeons. Their recommendations, published in the Annals of Surgical Oncology, tackle BCRL, …

View Post

Taselisib Added to Letrozole Boosts Response in Breast Cancer

In In The News by Barbara Jacoby0 Comments

By: Alexander M. Castellino, PhD From: medscape.com A new investigational PI3KCA targeted agent, taselisib (Genentech/Roche), has shown benefit in postmenopausal women with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) early-stage breast cancer. Adding the new agent to letrozole significantly improved response rates compared with letrozole alone in all patients, but the improvement was more robust for patients with …

View Post

DenseBreast-info.org Debuts Spanish Language Video about Dense Breasts

In In The News by Barbara Jacoby0 Comments

Breast cancer risks associated with breast density are the subject of a new Spanish language video launched this week by DenseBreast-info.org, recognized as the most up-to-date and comprehensive resource on the topic. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among Hispanic women, a population that is young and growing, yet underserved. During …

View Post

FDA clears mammography device with option for patient-assisted compression

In In The News by Barbara Jacoby0 Comments

SOURCE: U.S. Food and Drug Administration From: PR Newswire Today, the U.S. Food and Drug Administration cleared the first 2D digital mammography system that allows patients to increase or decrease the amount of compression applied to their own breast before the mammogram x-ray is taken. “Regular mammograms are an important tool in detecting breast cancer,” said Alberto Gutierrez, Ph.D., director …

View Post

THE UNDERSTUDIED CONSEQUENCES OF PERIPHERAL NEUROPATHY AFTER CHEMOTHERAPY

In In The News by Barbara Jacoby0 Comments

In two papers published in the Journal of the National Cancer Institute researchers from UC Davis, UCLA and other institutions have found that peripheral neuropathy, which causes pain, numbness, and tingling in hands and/or feet, can bother early-stage breast cancer patients years after completing chemotherapy. In addition, a systematic literature review found only a handful of studies that tracked long-term …